Paloma Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-9,636
| Closed | -$203K | – | 2177 |
|
2020
Q2 | $203K | Buy |
+9,636
| New | +$203K | ﹤0.01% | 1525 |
|
2019
Q2 | – | Sell |
-10,088
| Closed | -$229K | – | 1771 |
|
2019
Q1 | $229K | Buy |
+10,088
| New | +$229K | 0.01% | 1123 |
|
2017
Q3 | – | Sell |
-13,995
| Closed | -$558K | – | 1736 |
|
2017
Q2 | $558K | Sell |
13,995
-6,563
| -32% | -$262K | 0.01% | 1022 |
|
2017
Q1 | $757K | Buy |
20,558
+7,080
| +53% | +$261K | 0.01% | 965 |
|
2016
Q4 | $430K | Buy |
13,478
+477
| +4% | +$15.2K | ﹤0.01% | 1145 |
|
2016
Q3 | $471K | Buy |
13,001
+1,763
| +16% | +$63.9K | 0.01% | 982 |
|
2016
Q2 | $255K | Buy |
+11,238
| New | +$255K | ﹤0.01% | 1410 |
|